Evaluation and management of COVID-19-related severity in people with type 2 diabetes

Código QR

Evaluation and management of COVID-19-related severity in people with type 2 diabetes

Guardado en:

Detalles Bibliográficos
Autores principales:	Girish N Nadkarni, Bowen Wang, Deepak Vashishth
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Diseases of the endocrine glands. Clinical endocrinology RC648-665
Acceso en línea:	https://doaj.org/article/c1d9b518e2a4465788d776f6e1b931b2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Inequalities in glycemic management in people living with type 2 diabetes mellitus and severe mental illnesses: cohort study from the UK over 10 years
por: Robert Stewart, et al.
Publicado: (2021)

Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
por: Giesje Nefs, et al.
Publicado: (2021)

Fructose-induced severe hypertriglyceridemia and diabetes mellitus: a cautionary tale
por: Ana Dugic, et al.
Publicado: (2021)

Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program
por: William H Herman, et al.
Publicado: (2021)

Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
por: Nicola Quinn, et al.
Publicado: (2021)

Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
por: Marcus Lind, et al.
Publicado: (2021)

Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus
por: Rajesh Garg, et al.
Publicado: (2021)

Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP)
por: Frans Nollet, et al.
Publicado: (2021)

Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus
por: Lung-Wen Tsai, et al.
Publicado: (2021)

Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management Survey
por: Mitsuaki Hosoya, et al.
Publicado: (2021)

Fetal Abdominal Obesity Detected At 24 to 28 Weeks of Gestation Persists Until Delivery Despite Management of Gestational Diabetes Mellitus (Diabetes Metab J 2021;45:547-57)
por: Kyung-Soo Kim
Publicado: (2021)

Fetal Abdominal Obesity Detected at 24 to 28 Weeks of Gestation Persists until Delivery Despite Management of Gestational Diabetes Mellitus (Diabetes Metab J 2021;45:547-57)
por: Wonjin Kim, et al.
Publicado: (2021)

Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature
por: Soheila Torabiyan, et al.
Publicado: (2021)

Chronic-Care-Management Programs for Multimorbid Patients with Diabetes in Europe: A Scoping Review with the Aim to Identify the Best Practice
por: Julia Heike Brettel, et al.
Publicado: (2021)

Maternal and Fetal Outcomes in Women with Diabetes in Pregnancy Treated before and after the Introduction of a Standardized Multidisciplinary Management Protocol
por: Maddalena Morlando, et al.
Publicado: (2021)

Decreased serum C1Q/TNF-related protein 4 concentrations are associated with type 2 diabetes mellitus
por: Zheng Liu, et al.
Publicado: (2021)

Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic
por: Sergio Hernández-Jiménez, et al.
Publicado: (2021)

Healthy Eating and Active Lifestyles for Diabetes (HEAL-D), a culturally tailored self-management education and support program for type 2 diabetes in black-British adults: a randomized controlled feasibility trial
por: Fiona Reid, et al.
Publicado: (2021)

Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism
por: Zhi Yao, et al.
Publicado: (2021)

Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features
por: Adnan Haider, et al.
Publicado: (2021)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Peter Rossing, et al.
Publicado: (2021)

A Case of Diabetic Myonecrosis
por: Kyrstin L. Lane, MD, et al.
Publicado: (2021)

NAFLD in type 1 diabetes: overrated or underappreciated?
por: Jonathan Mertens, et al.
Publicado: (2021)

Digital health and diabetes: experience from India
por: Jothydev Kesavadev, et al.
Publicado: (2021)

An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus
por: Flavia Cristina Vasile, et al.
Publicado: (2021)

Social determinants of health impacting adherence to diabetic retinopathy examinations
por: Cindy X Cai, et al.
Publicado: (2021)

The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes
por: Na Zhao, et al.
Publicado: (2021)

Reverse Cholesterol Transport Pathway and Cholesterol Efflux in Diabetic Retinopathy
por: Xinyuan Zhang, et al.
Publicado: (2021)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
por: Mi-kyung Kim
Publicado: (2021)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
por: Eugene Han, et al.
Publicado: (2021)

An In Vitro Model of Diabetic Retinal Vascular Endothelial Dysfunction and Neuroretinal Degeneration
por: Qiyun Wang, et al.
Publicado: (2021)

Association of Phthalate Exposure with Thyroid Function and Thyroid Homeostasis Parameters in Type 2 Diabetes
por: Yi Chen, et al.
Publicado: (2021)

KM55 in the evaluation of IgA containing glomerular diseases
por: Rahul Raj, et al.
Publicado: (2021)

Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus
por: Denis A. Lebedev, et al.
Publicado: (2021)

Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
por: Femke Rutters, et al.
Publicado: (2021)

Human serum metabolomic analysis reveals progression for high blood pressure in type 2 diabetes mellitus
por: Li Li, et al.
Publicado: (2021)

GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes
por: Daniel Espes, et al.
Publicado: (2021)

Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
por: Lizheng Shi, et al.
Publicado: (2021)

Lower extremity MRI following 10-week supervised exercise intervention in patients with diabetic peripheral neuropathy
por: Nathan Davis, et al.
Publicado: (2021)

The Multiple Roles of B Lymphocytes in the Onset and Treatment of Type 1 Diabetes: Interactions between B Lymphocytes and T Cells
por: Yangfan Xiao, et al.
Publicado: (2021)